Prosthetic Rehabilitation of Thin Wiry Ridge by Ridge Splitting and Simultaneous Implants Placement

NCT ID: NCT06274476

Last Updated: 2024-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-09

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

evaluates the success of prosthetic rehabilitation of thin wiry ridge and implants placed simultaneously in splitted ridge both clinically and radiographically.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

twenty-one participants were enrolled of which 13 patients (8 females and 5 males) were suffering from maxillary ridge atrophy and 8 patients (5 females and 3 males) had mandibular ridge atrophy; a total of 42 implants were performed using the ridge expansion technique. The expansion was performed using the conventional disk technique, piezoelectric corticotomy, and self-threading expanders. Implants were placed and loaded with fixed partial denture after 4 months for the mandible and 6 months for the maxilla. Implant stability quotient (ISQ) was measured at T0 (implant placement) and TL (loading). Crestal bone levels were measured at different times: T0, TL, and T12 (12 months). Evaluation of prosthetic and surgical complications was carried out. Data were analyzed and compared using analysis of variance and paired t-tests at a significance level of 5%.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrophic Maxillary Ridge and Mandibular Ridge

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

maxillary and mandibular atrophic ridge
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
double

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

maxillary atrophic ridge

received ridge splitting done by piezo surgery and implant placement in maxillary arch

Group Type EXPERIMENTAL

implant placement

Intervention Type OTHER

ridge splitting piezo surgery and implant placement

mandibular atrophic ridge

received ridge splitting done by saw technique using ridge expanders and implant placement in maxillary arch

Group Type ACTIVE_COMPARATOR

implant placement

Intervention Type OTHER

ridge splitting piezo surgery and implant placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

implant placement

ridge splitting piezo surgery and implant placement

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

implant installation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ridge of 2 to 4 mm of initial alveolar crest width
* bone height of at least 8 mm from vitastructures

good oral hygiene.

Exclusion Criteria

patients who smoke more than 10 cigarettes per day diabetes mellitus, osteoporosis, and periodontal disease.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sharaf Mohamed Yahia

lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mohamed yahia Sharaf

Zagazig, Sharqia Province, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/9/9

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.